Factory directly Tilmicosin Oral Solution For Veterinary Use - Neomycin Sulfate Oral Solution – Jizhong
Factory directly Tilmicosin Oral Solution For Veterinary Use - Neomycin Sulfate Oral Solution – Jizhong Detail:
Neomycin Sulfate Oral Solution
Composition:
Contains per ml:
Neomycin Sulfate 200mg
Solvents ad 1ml
Description:
Neomycin has strong bactericidal effect on gram-negative bacillus.Internal use is rarely absorbed and is mostly excreted in its original form.Increased absorption occurs when the intestinal mucosa is inflamed or has an ulcer.
Indications:
For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to Neomycin sulfate in cattle( excluding veal calves), swine, sheep and goats.
Contra-indications:
Hypersensitivity to Neomycin.
Side effects:
Neomycin have nephrotoxicity, ototoxicity and neuromuscular blocking effect.
Dosage:
Calculated by Neomycin , mixed drinking, poultry 50-75mg, each 1L water for 3-5days.
Withdrawal times:
Chicken 5days. Forbidden using at egg laying.
Packaging:
Vial of 100ml.
Product detail pictures:
Related Product Guide:
owing to good service, a variety of high quality products, competitive prices and efficient delivery, we enjoy a good reputation among our customers. We are an energetic company with wide market for Factory directly Tilmicosin Oral Solution For Veterinary Use - Neomycin Sulfate Oral Solution – Jizhong , The product will supply to all over the world, such as: Norwegian, Lisbon, United Arab emirates, We are sticking to excellent quality, competitive price and punctual delivery and better service, and sincerely hope to establish long-term good relationships and cooperation with our new and old business partners from all over the world. Sincerely welcome you to join us.
By Jean Ascher from Uruguay - 2017.11.01 17:04
Product variety is complete, good quality and inexpensive, the delivery is fast and transport is security, very good, we are happy to cooperate with a reputable company!
By Natividad from Miami - 2018.06.18 19:26